A team of scientists from the University of New South Wales (UNSW) have conducted the first trials for treating depression with a go-to party drug, ketamine.
This hypothesis was started by Dr. Rupert McShane who explained the use of ketamine as an anti-depressant. Dr. McShane’s full proposal can be found via The Lancet.
In collaboration with the Black Dog Institute, 16 senior citizen patients with treatment-resistant depression were given different doses of ketamine. Perhaps an odd choice at first glance, it should be noted the results have been positive and scientists are considering this improvement a “big step forward.”
UNSW professor Colleen Loo spoke about the continued study:
“These findings take us a big step forward as we begin to fully understand the potential and limitations of ketamine’s antidepressant qualities. Not only was ketamine well-tolerated by participants, with none experiencing severe or problematic side effects, but giving the treatment by a simple subcutaneous injection (a small injection under the skin) was also shown to be an acceptable method for administering the drug in a safe and effective way.”
We’re very excited to see where how this potential treatment could benefit those with treatment-resistant depression. Of course, do not use ketamine without medical supervision with the hopes of curing depression.